Muscular Dystrophy, Duchenne Clinical Trials

6 recruitingLast updated: June 17, 2026

There are 6 actively recruiting muscular dystrophy, duchenne clinical trials across 4 countries. Studies span Not Applicable, Phase 3, Phase 1. Top locations include Columbus, Ohio, United States, Flower Mound, Texas, United States, Gdansk, Pomeranian Voivodeship, Poland. Updated daily from ClinicalTrials.gov.


Muscular Dystrophy, Duchenne Trials at a Glance

6 actively recruiting trials for muscular dystrophy, duchenne are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Columbus, Flower Mound, and Gdansk. Lead sponsors running muscular dystrophy, duchenne studies include Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille, and Dyne Therapeutics.

Browse muscular dystrophy, duchenne trials by phase

Treatments under study

About Muscular Dystrophy, Duchenne Clinical Trials

Looking for clinical trials for Muscular Dystrophy, Duchenne? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Muscular Dystrophy, Duchenne trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Muscular Dystrophy, Duchenne clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Cystic FibrosisHuntington DiseaseSickle Cell Disease+12 more
Assistance Publique - Hôpitaux de Paris550 enrolled1 locationNCT06147414
Recruiting
Phase 1

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc.83 enrolled7 locationsNCT04626674
Recruiting
Not Applicable

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

Upper ExtremityMuscular Dystrophy, DuchenneNeuromuscular Diseases (NMD)+6 more
Seoul National University Hospital30 enrolled1 locationNCT06363357
Recruiting
Not Applicable

Transcriptomic Analysis to Put an End to Misdiagnosis in Patients With Rare Muscle Diseases

Muscular Dystrophy, DuchenneMuscular Dystrophy, BeckerCongenital Myopathy+2 more
Assistance Publique Hopitaux De Marseille50 enrolled1 locationNCT06833489
Recruiting
Phase 3

The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD

Muscular Dystrophy, Duchenne
Medical University of Gdansk150 enrolled1 locationNCT05066633